220 related articles for article (PubMed ID: 32009091)
1. Lenalidomide Treatment for Thalidomide-refractory POEMS Syndrome: A Prospective Single-arm Clinical Trial.
Suichi T; Misawa S; Nagashima K; Sato Y; Iwai Y; Katayama K; Sekiguchi Y; Shibuya K; Amino H; Suzuki YI; Tsuneyama A; Nakamura K; Kuwabara S
Intern Med; 2020 May; 59(9):1149-1153. PubMed ID: 32009091
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial.
Misawa S; Sato Y; Katayama K; Nagashima K; Aoyagi R; Sekiguchi Y; Sobue G; Koike H; Yabe I; Sasaki H; Watanabe O; Takashima H; Nishizawa M; Kawachi I; Kusunoki S; Mitsui Y; Kikuchi S; Nakashima I; Ikeda S; Kohara N; Kanda T; Kira J; Hanaoka H; Kuwabara S;
Lancet Neurol; 2016 Oct; 15(11):1129-37. PubMed ID: 27496680
[TBL] [Abstract][Full Text] [Related]
3. A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome.
Li J; Huang XF; Cai QQ; Wang C; Cai H; Zhao H; Zhang L; Cao XX; Gale RP; Zhou DB
Am J Hematol; 2018 Jun; 93(6):803-809. PubMed ID: 29603764
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of POEMS syndrome with lenalidomide and dexamethasone].
Goto A; Iyama S; Sugama Y; Yoshida M; Ibata S; Tatekoshi A; Fujita C; Kikuchi S; Ikeda H; Murase K; Takada K; Kato J; Kobune M
Rinsho Ketsueki; 2019; 60(4):308-313. PubMed ID: 31068561
[TBL] [Abstract][Full Text] [Related]
5. Skin Responses in Newly Diagnosed Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes (POEMS) Syndrome After Therapy With Low-Dose Lenalidomide Plus Dexamethasone.
Gao Y; Zhang S; Yang L; Li J; Liu Y; Wang T
Front Immunol; 2021; 12():681360. PubMed ID: 34025681
[TBL] [Abstract][Full Text] [Related]
6. Japanese POEMS syndrome with Thalidomide (J-POST) Trial: study protocol for a phase II/III multicentre, randomised, double-blind, placebo-controlled trial.
Katayama K; Misawa S; Sato Y; Sobue G; Yabe I; Watanabe O; Nishizawa M; Kusunoki S; Kikuchi S; Nakashima I; Ikeda S; Kohara N; Kanda T; Kira J; Hanaoka H; Kuwabara S;
BMJ Open; 2015 Jan; 5(1):e007330. PubMed ID: 25573527
[TBL] [Abstract][Full Text] [Related]
7. Lenalidomide and dexamethasone in patients with POEMS syndrome: results of a prospective, open-label trial.
Nozza A; Terenghi F; Gallia F; Adami F; Briani C; Merlini G; Giordano L; Santoro A; Nobile-Orazio E
Br J Haematol; 2017 Dec; 179(5):748-755. PubMed ID: 29048107
[TBL] [Abstract][Full Text] [Related]
8. Improvement of sexual function in POEMS syndrome after combination therapy of Lenalidomide and dexamethasone.
Yang H; Huang X; Cai Q; Wang C; Cao X; Zhou D; Li J
Orphanet J Rare Dis; 2016 Jun; 11(1):80. PubMed ID: 27317315
[TBL] [Abstract][Full Text] [Related]
9. Lenalidomide as frontline therapy in polyneuropathy, organomegaly, endocrinopathy, monoclonal protein and skin changes syndrome: a retrospective case series of eight patients.
Lestang E; Caristan A; Néel A; Graveleau J; Duhamel E; Masseau A; Connault J; Maisonneuve H; Le Gouill S; Blin N; Touzeau C; Moreau P; Hamidou M
Leuk Lymphoma; 2015 Jun; 56(6):1895-6. PubMed ID: 25347429
[No Abstract] [Full Text] [Related]
10. Thalidomide reduces serum VEGF levels and improves peripheral neuropathy in POEMS syndrome.
Kuwabara S; Misawa S; Kanai K; Sawai S; Hattori T; Nishimura M; Nakaseko C
J Neurol Neurosurg Psychiatry; 2008 Nov; 79(11):1255-7. PubMed ID: 18469028
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of low-dose lenalidomide plus dexamethasone in patients with relapsed or refractory POEMS syndrome.
Cai QQ; Wang C; Cao XX; Cai H; Zhou DB; Li J
Eur J Haematol; 2015 Oct; 95(4):325-30. PubMed ID: 25401269
[TBL] [Abstract][Full Text] [Related]
12. Pachymeningeal involvement in POEMS syndrome: dramatic cerebral MRI improvement after lenalidomide therapy.
Briani C; Manara R; Lessi F; Citton V; Zambello R; Adami F
Am J Hematol; 2012 May; 87(5):539-41. PubMed ID: 22389216
[TBL] [Abstract][Full Text] [Related]
13. Combined Therapy with Ixazomib, Lenalidomide, and Dexamethasone for Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome.
Suichi T; Misawa S; Sekiguchi Y; Shibuya K; Nakamura K; Kano H; Aotsuka Y; Otani R; Morooka M; Tsukamoto S; Takeda Y; Mimura N; Ohwada C; Sakaida E; Kuwabara S
Intern Med; 2022; 61(17):2567-2572. PubMed ID: 36047093
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of novel agents in patients with nephropathy associated with POEMS syndrome.
Cheng S; Huang L; Fan W; Liang D; Zhu X; Jiang S; Ge Y
Int Urol Nephrol; 2022 Sep; 54(9):2317-2325. PubMed ID: 35133575
[TBL] [Abstract][Full Text] [Related]
15. Correlation of changes in serum level of VEGF and peripapillary retinal thickness in patients with POEMS syndrome.
Yokouchi H; Baba T; Misawa S; Oshitari T; Kuwabara S; Yamamoto S
Br J Ophthalmol; 2020 Jan; 104(1):33-38. PubMed ID: 30914422
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of lenalidomide in POEMS syndrome: a retrospective study of 20 patients.
Royer B; Merlusca L; Abraham J; Musset L; Haroche J; Choquet S; Leleu X; Sebban C; Decaux O; Galicier L; Roussel M; Recher C; Banos A; Guichard I; Brisseau JM; Godmer P; Hermine O; Deplanque G; Facon T; Asli B; Leblond V; Fermand JP; Marolleau JP; Jaccard A
Am J Hematol; 2013 Mar; 88(3):207-12. PubMed ID: 23335406
[TBL] [Abstract][Full Text] [Related]
17. [Rapid improvement of fluid retention with lenalidomide plus low-dose dexamethasone for POEMS syndrome relapsed after autologous peripheral blood stem cell transplantation].
Ohashi K; Yokoyama A; Kagoo T; Hosoda T; Yamamoto R; Yoneda M; Kudo M; Boku S; Ueno H; Yano T
Rinsho Ketsueki; 2013 Jul; 54(7):670-4. PubMed ID: 23912352
[TBL] [Abstract][Full Text] [Related]
18. Lenalidomide in patients with POEMS syndrome: a systematic review and pooled analysis.
Zagouri F; Kastritis E; Gavriatopoulou M; Sergentanis TN; Psaltopoulou T; Terpos E; Dimopoulos MA
Leuk Lymphoma; 2014 Sep; 55(9):2018-23. PubMed ID: 24295131
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study.
Misawa S; Sato Y; Katayama K; Hanaoka H; Sawai S; Beppu M; Nomura F; Shibuya K; Sekiguchi Y; Iwai Y; Watanabe K; Amino H; Ohwada C; Takeuchi M; Sakaida E; Nakaseko C; Kuwabara S
BMJ Open; 2015 Nov; 5(11):e009157. PubMed ID: 26560063
[TBL] [Abstract][Full Text] [Related]
20. Lenalidomide-Induced Ischemic Cerebrovascular Disease in Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome.
Mitsutake A; Matsumoto H; Hatano K; Irie K; Tsukada N; Hashida H
J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):e102-e103. PubMed ID: 29395638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]